Gambia deaths: US FDA issues alert

The FDA said manufacturers must perform the DEG and EG limit test on representative samples of each shipment of each lot of the component and ensure that the component contains no more than 0.10% of DEG and EG before using it in the drug.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/zLQDvuo
via IFTTT